IB 

Union Calendar No. 34 

118TH CONGRESS 

1ST SESSION H. R. 1734 

[Report No. 118–50] 

To require coordinated National Institute of Standards and Technology 

science and research activities regarding illicit drugs containing xylazine, 

novel synthetic opioids, and other substances of concern, and for other 

purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 23, 2023 

Mr. COLLINS (for himself, Ms. CARAVEO, Mr. LUCAS, Ms. LOFGREN, Mr. 

CRAWFORD, Mrs. FOUSHEE, Mr. OBERNOLTE, Mrs. MCCLELLAN, Mr. 

KEAN of New Jersey, Ms. ROSS, Mr. MIKE GARCIA of California, Mr. 

MULLIN, Ms. TENNEY, Mr. SORENSEN, Mr. WILLIAMS of New York, Mr. 

TRONE, Mr. WEBER of Texas, Mr. BABIN, and Mr. STRONG) introduced 

the following bill; which was referred to the Committee on Science, Space, 

and Technology 

MAY 5, 2023 

Additional sponsors: Mr. C. SCOTT FRANKLIN of Florida, Mr. MILLER of 

Ohio, Mr. JACKSON of North Carolina, Ms. STEVENS, Mrs. SYKES, Ms. 

LEE of Pennsylvania, and Mr. PAPPAS

MAY 5, 2023 

Reported with an amendment, committed to the Committee of the Whole 

House on the State of the Union, and ordered to be printed 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HR 1734 RH

A BILL 

To require coordinated National Institute of Standards and 

Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, 

and other substances of concern, and for other purposes. 


pbinns on DSKJLVW7X2PROD with $$_JOB
3 

•HR 1734 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Testing, Rapid Anal5 ysis, and Narcotic Quality Research Act’’ or the ‘‘TRANQ 

6 Research Act’’. 

7 SEC. 2. XYLAZINE DETECTION AND ANALYSIS. 

8 (a) IN GENERAL.—The Director shall— 

9 (1) support NIST intramural basic measure10 ment science and research to advance— 

11 (A) analytical methods to identify, under12 stand, differentiate, and categorize illicit drugs 

13 containing xylazine, novel synthetic opioids, or 

14 other emerging substances of concern; 

15 (B) measurement technologies to shorten 

16 analysis timelines and enhance narcotic and 

17 opioid detection and analysis capabilities in il18 licit drugs; 

19 (C) new data tools, techniques, and proc20 esses to identify and publicly disclose relevant 

21 information concerning illicit drugs containing 

22 xylazine, novel synthetic opioids, or other 

23 emerging substances of concern; and 

24 (D) all other areas determined by the Di25 rector to be critical to the development and deVerDate Sep 11 2014 22:48 May 05, 2023 Jkt 039200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H1734.RH H1734

pbinns on DSKJLVW7X2PROD with $$_JOB
4 

•HR 1734 RH

1 ployment of technologies to measure and ana2 lyze the presence of xylazine, novel synthetic 

3 opioids, and other emerging substances of con4 cern in illicit drugs; 

5 (2) support activities to inform and expand the 

6 development of near-real time spectrometry capabili7 ties regarding xylazine, novel synthetic opioids, and 

8 other emerging compounds in illicit drugs; 

9 (3) convene the private sector, institutions of 

10 higher education, nonprofit organizations, Federal 

11 laboratories, and other Federal agencies engaged in 

12 the analysis of illicit drugs to develop coordinated 

13 strategies and voluntary best practices for the safe 

14 handling, transport, and analysis of illicit drugs con15 taining xylazine, novel synthetic opioids, or other 

16 emerging substances of concern; 

17 (4) establish or expand collaborative partner18 ships or consortia with other government agencies 

19 engaged in counternarcotic research and develop20 ment, institutions of higher education, Federal lab21 oratories, and the private sector to enhance narcotic 

22 and opioid detection and analysis capabilities regard23 ing xylazine, novel synthetic opioids, and other 

24 emerging substances of concern in illicit drugs; and 


pbinns on DSKJLVW7X2PROD with $$_JOB
5 

•HR 1734 RH

1 (5) provide opportunities for graduate and post2 graduate research on the detection and identification 

3 of xylazine, novel synthetic opioids, and other emerg4 ing substances of concern in illicit drugs. 

5 (b) CONTROLS.—In carrying out activities authorized 

6 under this section, the Director shall ensure proper secu7 rity controls are implemented to protect sensitive informa8 tion, as appropriate. 

9 (c) DEFINITIONS.—In this section: 

10 (1) DIRECTOR.—The term ‘‘Director’’ means 

11 the Director of the National Institute of Standards 

12 and Technology. 

13 (2) FEDERAL LABORATORY.—The term ‘‘Fed14 eral laboratory’’ has the meaning given such term in 

15 section 4 of the Stevenson-Wydler Technology Inno16 vation Act of 1980 (15 U.S.C. 3703). 

17 (3) INSTITUTION OF HIGHER EDUCATION.—The 

18 term ‘‘institution of higher education’’ has the 

19 meaning given such term in section 101 of the High20 er Education Act of 1965 (19 U.S.C. 1001). 

21 (4) NIST.—The term ‘‘NIST’’ means the Na22 tional Institute of Standards and Technology. 

23 (5) NONPROFIT ORGANIZATION.—The term 

24 ‘‘nonprofit organization’’ means an organization de25 scribed in section 501(c)(3) of the Internal Revenue 


pbinns on DSKJLVW7X2PROD with $$_JOB
6 

•HR 1734 RH

1 Code of 1986 and exempt from tax under section 

2 501(a) of such code. 

3 (6) XYLAZINE.—The term ‘‘xylazine’’ means 

4 the nonopioid tranquilizer methyl benzene compound 

5 frequently used in veterinary medicine as an emetic 

6 and sedative with analgesic and muscle relaxant 

7 properties. 

8 SEC. 3. REPORT. 

9 Not later that 1 year after the date of enactment of 

10 this Act, the Director of the National Institute of Standards 

11 and Technology shall submit to the Committee on Science, 

12 Space, and Technology of the House of Representatives and 

13 the Committee on Commerce, Science, and Transportation 

14 of the Senate a report on the implementation of this Act. 

15 Such report may include legislative recommendations to 

16 improve the Director’s ability to carry out section 2. 


pbinns on DSKJLVW7X2PROD with $$_JOB

pbinns on DSKJLVW7X2PROD with $$_JOB
Union Calendar No. 34 

118TH CONGRESS 

1ST SESSION H. R. 1734 

[Report No. 118–50] 

A BILL 

To require coordinated National Institute of Standconcern, and for other purposes. novel synthetic opioids, and other substances of ties regarding illicit drugs containing xylazine, ards and Technology science and research activiMAY 5, 2023 

Reported with an amendment, committed to the Comand ordered to be printed mittee of the Whole House on the State of the Union, 


pbinns on DSKJLVW7X2PROD with $$_JOB